Amendments in Standard Input Output Norms (SION) A-222 for export of Erythromycin Stearate Tablet.
(TO BE PUBLISHED IN THE GAZETTE OF INDIA EXTRAORDINARY (PART-1
(SECTION-1)
Government of India
Ministry of Commerce & Industry
Department of Commerce
Directorate General of Foreign Trade
Public Notice No.46 /2024-25
New Delhi, Dated February, 2025
Subject: Amendments in Standard Input Output Norms (SION) A-222 for export of Erythromycin Stearate Tablet.
In exercise of the powers conferred under paragraphs 1.03 and 2.04 of the Foreign Trade Policy-2023 as amended from time to time, the Director General of Foreign Trade makes the following amendments in Standard Input Output Norms (SION) A-222 for export of Erythromycin Stearate Tablet.
| SI. No. | Import Item/s | z Quantity 4 |
|---|---|---|
| I | Erythromycin Stearate | 334 mg. |
Note: For other variants of export items, norms may be worked out on a pro-rata basis.
Effect of the Public Notice: Standard Input Output Norm appearing under A-222 is amended as above with immediate effect.
Ww
;
a
(Santosh Sarangi)
Director General of Foreign Trade
Ex-officio Addl. Secretary to the Government of India e-mail: dgft@nic.in
(issued from File No.
Source: Directorate General of Foreign Trade (DGFT). View the official PDF.